Abstract
Increasing evidence of pro-inflammatory mediator expression in major depressions indicate that inflammatory changes may play a role. If this is true, the efficacy of antidepressants may be partially attributable to suppression of inflammation. Various types of antidepressants can suppress serum and plasma levels of pro-inflammatory mediators in patients with major depression. Therefore they can inhibit the production of pro-inflammatory mediators by immune cells. These include glial cells, which are the main sources and targets of cytokines in the brain. This review summarizes the evidence showing that antidepressants have an anti-inflammatory potential. The putative mechanisms are also discussed. Because of the anti-inflammatory effects of antidepressants, they might also act as preventives for neurodegenerative dementias including Alzheimers disease, where the pathogenesis involves chronic inflammation associated with activated microglia.
Keywords: Antidepressants, major depression, Alzheimer's disease, inflammation, cytokines, microglia
Central Nervous System Agents in Medicinal Chemistry
Title: Anti-Inflammatory Effects of Antidepressants: Possibilities for Preventives Against Alzheimers Disease
Volume: 9 Issue: 1
Author(s): Sadayuki Hashioka, Patrick L. McGeer, Akira Monji and Shigenobu Kanba
Affiliation:
Keywords: Antidepressants, major depression, Alzheimer's disease, inflammation, cytokines, microglia
Abstract: Increasing evidence of pro-inflammatory mediator expression in major depressions indicate that inflammatory changes may play a role. If this is true, the efficacy of antidepressants may be partially attributable to suppression of inflammation. Various types of antidepressants can suppress serum and plasma levels of pro-inflammatory mediators in patients with major depression. Therefore they can inhibit the production of pro-inflammatory mediators by immune cells. These include glial cells, which are the main sources and targets of cytokines in the brain. This review summarizes the evidence showing that antidepressants have an anti-inflammatory potential. The putative mechanisms are also discussed. Because of the anti-inflammatory effects of antidepressants, they might also act as preventives for neurodegenerative dementias including Alzheimers disease, where the pathogenesis involves chronic inflammation associated with activated microglia.
Export Options
About this article
Cite this article as:
Hashioka Sadayuki, McGeer L. Patrick, Monji Akira and Kanba Shigenobu, Anti-Inflammatory Effects of Antidepressants: Possibilities for Preventives Against Alzheimers Disease, Central Nervous System Agents in Medicinal Chemistry 2009; 9 (1) . https://dx.doi.org/10.2174/187152409787601897
DOI https://dx.doi.org/10.2174/187152409787601897 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Neurobiological Mechanisms and Treatments of REM Sleep Disturbances in Depression
Current Neuropharmacology Conference Report: The Myriad Pathways of Neurodegeneration Discussed at NEUROCON 2015
Current Aging Science “Nutritional Psychiatry: Evidence of the Role of Foods in Mental Health” Part 1
Current Pharmaceutical Biotechnology Meet Our Editorial Board Member:
Current Neuropharmacology Brain Ageing, Cognition and Diet: A Review of the Emerging Roles of Food-Based Nootropics in Mitigating Age-related Memory Decline
Current Aging Science Diagnosis and Management of Endocrine Hypertension in Children and Adolescents
Current Pharmaceutical Design Biocatalysis in the Pharmaceutical Industry. A Greener Future
Current Green Chemistry Curcumin Suppresses Tumor Growth and Angiogenesis in Human Glioma Cells Through Modulation of Vascular Endothelial Growth Factor/ Angiopoietin-2/Thrombospondin-1 Signaling
CNS & Neurological Disorders - Drug Targets Treatment of Hypertensive Left Ventricular Hypertrophy
Current Pharmaceutical Design Metabolic and Cardiovascular Complications of Highly Active Antiretroviral Therapy for HIV Infection
Current HIV Research Anti-inflammatory Effects of Dietary Antioxidants
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Association of Fractalkine Receptor (T280M) Polymorphism in the Pathogenesis of Acute Coronary Syndrome in the Egyptian Population
Current Pharmaceutical Biotechnology Interactions of Ginkgolides A and B with a Recombinant Human Prion Protein
Protein & Peptide Letters Substance P in Rheumatic Diseases
Current Rheumatology Reviews Herb-Drug Interactions in Neurological Disorders: A Critical Appraisal
Current Drug Metabolism The Role for Oxidative Stress in Aberrant DNA Methylation in Alzheimer’s Disease
Current Alzheimer Research East Meets West in the Search for Alzheimers Therapeutics - Novel Dimeric Inhibitors from Tacrine and Huperzine A
Current Alzheimer Research Association between <i>Toxoplasma gondii</i> Infection and Headache: A Systematic Review and Meta-Analysis
Infectious Disorders - Drug Targets An Optimal Approach for Selecting Discriminant Regions for the Diagnosis of Alzheimer's Disease
Current Alzheimer Research Clinical Trajectories and Biological Features of Primary Progressive Aphasia (PPA)
Current Alzheimer Research